Compare Roblox Corp (RBLX) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roblox Corp vs Relay Therapeutics Inc. Common Stock — how do they compare? Roblox Corp trades at $48.12 (market cap $32.52B), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: Roblox Corp is far larger — about 8.5× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roblox Corp for 93 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| RBLX | RLAY | |
|---|---|---|
Market Cap | $32.52B | $3.82B |
Volume | 14,552,045 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $138.56 | $20.75 |
52-Week Low | $35.54 | $6.03 |
Typical Hold Time | 93 Days | 0 Days |
Enterprise Value | $31.34B | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RBLX trades at $48.09, up 3.62% today, showing strong momentum despite a bearish technical signal. The stock has beaten earnings expectations for three consecutive quarters, with revenue growing from $2.2B in 2022 to $4.9B in 2025. However, the company remains unprofitable with a net income margin of -17.61% and negative ROE of -396.28%. Recent news highlights mixed sentiment, including a Jefferies downgrade to Underperform on September 28, 2026, citing concerns about bookings growth, offset by optimism around AI tools unveiled at the developer conference.
The outlook for RBLX hinges on balancing robust revenue growth against persistent losses. The consensus price target of $50.85 suggests modest upside, but high P/B of 213.94 and negative profitability metrics pose risks. Key opportunities include AI-driven creator tools and expanding user engagement, while threats involve booking deceleration and competitive pressure. Investors should weigh the company's growth trajectory against its path to profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
